Edition:
United States

Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

8,922JPY
22 Feb 2019
Change (% chg)

¥-113 (-1.25%)
Prev Close
¥9,035
Open
¥8,992
Day's High
¥9,020
Day's Low
¥8,887
Volume
591,900
Avg. Vol
877,716
52-wk High
¥11,490
52-wk Low
¥5,526

Chart for

About

Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic... (more)

Overall

Beta: 0.93
Market Cap(Mil.): ¥2,645,970.00
Shares Outstanding(Mil.): 296.57
Dividend: 80.00
Yield (%): 1.68

Financials

  4523.T Industry Sector
P/E (TTM): 40.13 32.35 35.75
EPS (TTM): 222.30 -- --
ROI: 8.90 13.02 12.61
ROE: 10.71 14.07 13.81

Eisai, Biogen Alzheimer's data fails to convince skeptics

Eisai Co Ltd and partner Biogen Inc said on Thursday that the highest dose of their experimental Alzheimer's disease drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data and Biogen shares fell about 2 percent.

Oct 25 2018

UPDATE 2-Eisai, Biogen Alzheimer's data fails to convince skeptics

Oct 25 Eisai Co Ltd and partner Biogen Inc said on Thursday that the highest dose of their experimental Alzheimer's disease drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data and Biogen shares fell about 2 percent.

Oct 25 2018

UPDATE 1-Biogen shares slip after Alzheimer's data fails to convince

Oct 25 Biogen Inc and partner Eisai Co Ltd said on Thursday the highest dose of its experimental Alzheimer's drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data.

Oct 25 2018

Biogen/Eisai Alzheimer's data suggests treatment effect related to drug

Oct 25 Biogen and partner Eisai Co Ltd said data from their experimental Alzheimer's drug suggested that the treatment effect for the highest dose was related to the drug, and not to an imbalance of patients in the treatment groups.

Oct 25 2018

Nikkei rises to 2-week high on weak yen, pharmaceuticals

* Paper sector pushed up by brokerage's target price hike on co

Aug 24 2018

Nikkei rises as weak yen helps mood; Eisai soars

TOKYO, Aug 24 Japan's Nikkei rose on Friday as a weaker yen supported sentiment, with the pharmaceutical sector leading gains after a report that Eisai moved forward its mid-term profit goal by one year.

Aug 23 2018

Earnings vs. Estimates